Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare announces 2021 investor series

Investor Presentation3 May 2021FPHHealthcare

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


Fisher & Paykel Healthcare announces 2021 Investor Series


Auckland, New Zealand, 4 May 2021 - Fisher & Paykel Healthcare Corporation Limited today

announced it will hold a virtual Investor Series over three days between 1 June and 3 June 2021

(NZST).


The Investor Series will provide participants with the opportunity to hear from management based

in New Zealand and the United States on our technology and therapies and gain further insights

into our strategy for long-term sustainable profitable growth. The series will be presented via

webcast through three one-hour presentations over three days including Q&A sessions with

management.


Event: Fisher & Paykel Healthcare 2021 Investor Series

Programme:

Day 1 1 June 2021, 1:00pm – 2:00pm NZST Introduction to sustainable profitable growth

1 June 2021, 11:00am – 12:00pm AEST Hospital Respiratory Support

31 May 2021, 9:00pm – 10:00pm USEDT

Day 2 2 June 2021, 1:00pm – 2:00pm NZST Home Respiratory Support

2 June 2021, 11:00am – 12:00pm AEST Surgical Humidification

1 June 2021, 9:00pm – 10:00pm USEDT

Day 3 3 June 2021, 1:00pm – 2:00pm NZST Expanding global reach

3 June 2021, 11:00am – 12:00pm AEST Concluding comments

2 June 2021, 9:00pm – 10:00pm USEDT


Please register at the following site and details on how to access the webcast will be provided to

you prior to the event: https://www.fphcare.com/investor-series



Investors and analysts will be able to ask questions via the webcast. While every endeavour will be

made to answer all questions that are submitted, this may not be possible due to time constraints.


Registrations close 30 May 2021.


About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and

systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive

sleep apnea. The company’s products are sold in over 120 countries worldwide. For more

information about the company visit www.fphcare.com



Ends


Contacts:

Media:

Karen Knott

Senior Communications Manager

karen.knott@fphcare.co.nz

+64 (0) 21 713 911

Investors:

Hayden Brown

Investor Relations Manager

hayden.brown@fphcare.co.nz

+64 (0) 27 807 8073



Authorised by:

Marcus Driller

VP Corporate and Company Secretary.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.